for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Abeona Therapeutics Reinitiates Enrollment In EB-101 Pivotal Phase 3 Viital™ Study In RDEB After Covid-19 Related Pause

July 8 (Reuters) - Abeona Therapeutics Inc:

* ABEONA THERAPEUTICS REINITIATES ENROLLMENT IN EB-101 PIVOTAL PHASE 3 VIITAL™ STUDY IN RDEB AFTER COVID-19 RELATED PAUSE AND ANNOUNCES PROGRESS IN PATIENT ENROLLMENT IN MPS III STUDIES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up